RAB6A is a human gene whose product Rab6A is a Golgi-resident small GTPase that regulates retrograde transport from the Golgi to the endoplasmic reticulum. It plays critical roles in vesicle trafficking, Golgi organization, and neuronal protein sorting. Rab6A is one of the most abundant RAB proteins in the brain and is essential for maintaining neuronal homeostasis. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration .
Full NameRAB6A, Member RAS Oncogene Family
[^2]
Chromosome2q37.1
NCBI Gene ID[5872](https://www.ncbi.nlm.nih.gov/gene/5872)
OMIM[179512](https://omim.org/entry/179512)
Ensembl[ENSG00000168244](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000168244)
UniProt[P20340](https://www.uniprot.org/uniprot/P20340)
ProteinRab6A
Associated DiseasesAlzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Hereditary Spastic Paraplegia
RAB6A is a Golgi-resident small GTPase that regulates retrograde transport from the Golgi to the endoplasmic reticulum (ER). As a member of the RAB GTPase family, Rab6A cycles between an active GTP-bound state and an inactive GDP-bound state, with this cycling controlled by GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs) .
Rab6A performs several critical cellular functions:
- Retrograde Transport: Rab6A coordinates the retrieval of cargo from the Golgi back to the ER, a fundamental process for maintaining ER-Golgi homeostasis
- Golgi Organization: The protein maintains Golgi stack morphology and function through regulation of COPI vesicle trafficking
- Vesicle Tethering: Rab6A interacts with effector proteins including p115, GM130, and GRASP65 to tether vesicles to their correct destinations
- Cytoskeletal Regulation: Rab6A modulates microtubule-based transport and interacts with dynein/dynactin motor complexes
In neurons, Rab6A is particularly important for:
- Synaptic Vesicle Recycling: Rab6A regulates the retrieval of synaptic vesicle components after neurotransmitter release
- Protein Quality Control: The Golgi-ER retrieval pathway is essential for disposing of misfolded proteins and maintaining proteostasis
- Axonal Transport: Rab6A-mediated trafficking is crucial for transporting proteins along axons and dendrites
- Dendritic Spine Morphogenesis: Rab6A function influences the formation and maintenance of dendritic spines
RAB6A dysfunction has been implicated in Alzheimer's disease pathogenesis through multiple mechanisms :
- Amyloid Precursor Protein (APP) Processing: Altered Rab6A activity affects APP trafficking and processing in the secretory pathway, potentially influencing amyloid-beta production
- Tau Pathology: Rab6A-mediated transport defects may contribute to tau hyperphosphorylation and NFT formation
- Endoplasmic Reticulum Stress: Impaired retrograde transport leads to ER stress and activation of the unfolded protein response
- Synaptic Dysfunction: Rab6A deficiency contributes to synaptic vesicle recycling deficits and memory impairment
In Parkinson's disease, RAB6A plays protective roles :
- Alpha-Synuclein Trafficking: Rab6A regulates the intracellular trafficking of alpha-synuclein and may influence its aggregation
- Lysosomal Function: Rab6A-mediated retrograde transport delivers proteins to lysosomes for degradation
- Mitochondrial Quality Control: Rab6A dysfunction may exacerbate mitochondrial dysfunction in dopaminergic neurons
- Autophagy: Rab6A is involved in autophagosome formation and maturation
RAB6A is implicated in ALS through :
- TDP-43 Pathology: Rab6A-mediated transport defects may contribute to TDP-43 mislocalization
- Axonal Transport Deficits: RAB6A mutations or reduced expression impair axonal transport
- Protein Aggregation: Impaired retrograde transport leads to accumulation of misfolded proteins
- Motor Neuron Vulnerability: Rab6A is highly expressed in motor neurons, which are selectively affected in ALS
Mutations in RAB6A-interacting proteins cause hereditary spastic paraplegia, confirming its importance in axonal health .
RAB6A is ubiquitously expressed with highest levels in:
- Brain: Particularly in neurons of the basal ganglia, hippocampus, cerebral cortex, and motor neurons of the spinal cord
- Testis: High expression in male germ cells
- Pancreas: Moderate expression in pancreatic cells
In the brain, Rab6A localizes to the Golgi apparatus of neurons and is enriched in synaptic terminals .
RAB6A represents a potential therapeutic target for neurodegenerative diseases :
- Enhancing Retrograde Transport: Small molecules that activate Rab6A could improve protein quality control
- Modulating Autophagy: Rab6A activators may enhance autophagic clearance of toxic proteins
- Synaptic Protection: Rab6A-boosting strategies could protect synaptic function
- Combination Therapies: Rab6A modulators may synergize with other approaches targeting amyloid-beta, tau, or alpha-synuclein
Key Rab6A-interacting proteins include :
- p115 (UBL4A): Vesicle tethering factor
- GM130 (GOLGA2): Golgi matrix protein
- GRASP65 (GORASP1): Golgi stacking protein
- Dynein/Dynactin: Motor protein complex for retrograde transport
- MICAL1: Rab6A effector involved in cytoskeletal regulation